CAS RN: 2231664-15-4
(2S,3R)-3-fluoro-2-methylazetidine hydrochloride
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250826
100mg / 500mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g, 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2231664-15-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
5g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2231664-15-4 / (2S,3R)-3-fluoro-2-methylazetidine;hydrochloride
Standard CAS: 2231664-15-4
Multi CAS: No
Basic Information
copy
CAS
2231664-15-4 copy
Multi CAS
No copy
Molecular Formula
C4H9ClFN copy
Molecular Weight
125.570000 copy
Exact Mass
125.040755 copy
SMILES
C[C@H]1[C@@H](CN1)F.Cl copy
InChI
InChI=1S/C4H8FN.ClH/c1-3-4(5)2-6-3;/h3-4,6H,2H2,1H3;1H/t3-,4+;/m0./s1 copy
InChIKey
LCIMHSJEJTYTNF-RFKZQXLXSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
7 copy
Fraction Csp3
1 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
29.61 copy
TPSA
12.03 copy
LogP / Solubility
WLOGP
0.74 copy
MLOGP
0.64 copy
XLogP3
0.74 copy
Consensus LogP
0.71 copy
Log S (ESOL)
-1.08 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.12 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.09 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.96 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy